Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Vitamin D status and Covid-19 in Saudi Settings: A randomized open-label study on the possible role of vitamin D on improving clinical outcomes KKUH Ongoing VITA-D 3 H-01-R-012 King Fahad Medical City (Riyadh)
Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers Qassim University Completed Vitamin C (ascorbic acid ) Cevital 3 20111803 Mental Health Hospital (Abha)
V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy MSD Completed V212 3 V212-011 KFSH
Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue" King Faisal Specialist Hospital and Research Centre Ongoing Everolimus 2 ONC-CRC 12- 12 or (RAC # 2121 159) KFSH & RC-R
"Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial" London School of Hygiene & Tropical Medicine (LSHTM) Ongoing (Cyklokapron) Tranexamic Acid 3 ISRCTN15088122 KSMC
"Tranexamic acid for the treatment of gastrointestinal hemorrhage: an international randomized, double-blind, placebo-controlled trial" Prince Mohammad Bin Abdulaziz Hospital Ongoing Tranexamic acid 3 ISRCTN11225767 PMBAH
Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF Roche Completed Tocilizumab 3 ML22726 KFSH
THydroxychloroquine versus Standard of Care for the Management of COVID-19 King Abdulaziz University Hospital Completed Hydroxychloroquine sulphate 3 249-20 KAUH-J
Therapeutic Effects of Colchicine in the Treatment of Symptomatic and Acute Respiratory Distress Syndrome in COVID-19 Patients KACST Completed Colchicine 3 5200107 DCH
The study of efficacy and saftey of Rituximab in treatment of resistant glomerulonephritis The Saudi center for Organ Transplantation (SCOT) Completed Rituximab 3 MN-101-11 KFMC
View 231 - 240 From 816